3.0.0 6190 2022-03-01T06:10:55Z 2022-03-01T06:10:55Z House H HR 2012-07-25 112 From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. BURGESS:H.R. 6190.Congress has the power to enact this legislation pursuantto the following:The attached legislation falls within Congress' authorityto regulate interstate commerce as found in Article I,Section 8, clause 3 of the U.S. Constitution, which providesthe authority for the Congress to ``To regulate Commerce withforeign Nations, and among the several States, and with theIndian Tribes.'' The epinephrine inhalers at issue in theattached legislation are regulated by the federal Food andDrug Administration (FDA), and the propellant at issue isregulated by the Environmental Protection Agency. The productfurther falls within the subject matter of an internationaltreaty known as the Montreal Protocol on Substances thatDeplete the Ozone Layer, of which the U.S. is a signatory.[Page H5292]]]> hsif00 Energy and Commerce Committee House Standing hsif03 Energy, Climate and Grid Security Subcommittee Referred to 2012-07-27T13:47:23Z Reported by 2012-09-14T19:24:26Z Referred to 2012-07-25T14:01:10Z H. Rept. 112-673 2012-12-12 17:20:10 On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 229 - 182 (Roll no. 623). Floor H37300 2 House floor actions 623 https://clerk.house.gov/evs/2012/roll623.xml House 112 2012-12-12T22:20:10Z 2 2012-12-12 17:20:10 Failed of passage/not agreed to in House: On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 229 - 182 (Roll no. 623). Floor 9000 9 Library of Congress 623 https://clerk.house.gov/evs/2012/roll623.xml House 112 2012-12-12T22:20:10Z 2 2012-12-12 17:12:55 Considered as unfinished business. (consideration: CR H6740-6741) Floor H30000 2 House floor actions 2012-12-12 14:31:50 At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed. Floor H37220 2 House floor actions 2012-12-12 13:53:40 DEBATE - The House proceeded with forty minutes of debate on H.R. 6190. Floor H8D000 2 House floor actions 2012-12-12 13:53:37 Considered under suspension of the rules. (consideration: CR H6724-6728; text of measure as reported in House: CR H6724) Floor H30000 2 House floor actions 2012-12-12 13:53:15 Mr. Burgess moved to suspend the rules and pass the bill. Floor H30300 2 House floor actions 2012-09-14 Placed on the Union Calendar, Calendar No. 485. Calendars H12410 2 House floor actions U00485 2012-09-14 Reported by the Committee on Energy and Commerce. H. Rept. 112-673. Committee H12200 2 House floor actions hsif00 Energy and Commerce Committee 2012-09-14 Reported by the Committee on Energy and Commerce. H. Rept. 112-673. Committee 5000 9 Library of Congress hsif00 Energy and Commerce Committee 2012-07-27 hsif03 Energy, Climate and Grid Security Subcommittee 1 House committee actions Referred to the Subcommittee on Energy and Power. Committee 2012-07-25 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2012-07-25 Introduced in House IntroReferral Intro-H 9 Library of Congress 2012-07-25 Introduced in House IntroReferral 1000 9 Library of Congress B001248 Rep. Burgess, Michael C. [R-TX-26] Michael Burgess R TX C. 26 N R000573 Rep. Ross, Mike [D-AR-4] MIKE ROSS D AR 4 2012-07-25 True B000213 Rep. Barton, Joe [R-TX-6] JOE BARTON R TX L. 6 2012-07-25 True P000373 Rep. Pitts, Joseph R. [R-PA-16] JOSEPH PITTS R PA R. 16 2012-07-25 True C001051 Rep. Carter, John R. [R-TX-31] John Carter R TX R. 31 2012-07-25 True M001142 Rep. Matheson, Jim [D-UT-2] JIM MATHESON D UT 2 2012-07-25 True Environmental Protection Administrative law and regulatory procedures Air quality Cardiovascular and respiratory health Climate change and greenhouse gases Environmental Protection Agency (EPA) Environmental regulatory procedures Health technology, devices, supplies Environmental Protection 00 2012-07-25 Introduced in House 2012-10-31T21:13:04Z Asthma Inhalers Relief Act of 2012 - Directs the Administrator of the Environmental Protection Agency (EPA) to: (1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act; (2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and (3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.

Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.

Terminates this Act on August 1, 2013.

]]> 79 2012-09-14 Reported to House without amendment 2012-11-13T18:28:10Z (This measure has not been amended since it was introduced. The summary of that version is repeated here.)

Asthma Inhalers Relief Act of 2012 - Directs the Administrator of the Environmental Protection Agency (EPA) to: (1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act; (2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and (3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.

Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.

Terminates this Act on August 1, 2013.

]]> Asthma Inhalers Relief Act of 2012 Short Titles as Introduced Asthma Inhalers Relief Act of 2012 Short Titles as Reported to House Asthma Inhalers Relief Act of 2012 H House Display Title Asthma Inhalers Relief Act of 2012 Official Title as Introduced To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inventories of over-the-counter CFC epinephrine inhalers. Reported in House 2012-09-14T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-112hr6190rh/xml/BILLS-112hr6190rh.xml Introduced in House 2012-07-25T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-112hr6190ih/xml/BILLS-112hr6190ih.xml 2012-12-12 On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 229 - 182 (Roll no. 623). 17:20:10 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.